RESUMEN
BACKGROUND: Ethyl chloride is commercially available as a DVD/VCR cleaner, and can be found as a gasoline additive and topical anesthetic. There is an emerging trend of recreational huffing to enhance sexual relations. Neurotoxicity from repeated abuse is uncommon. CASE REPORT: A 36-year-old man with a history of intermittent ethyl chloride use for 15 years presented to the Emergency Department with an inability to walk for 4 days after frequent use for 1 week. The patient reported a rapid titration of inhalation from zero to eight cans of 4.6 oz ethyl chloride aerosol per day over a 1-week period. Initial vital signs were heart rate 88 beats/min, blood pressure 147/60 mm Hg, temperature 37.2°C (99°F), and respiratory rate 16 breaths/min. Physical examination was notable for slurred speech, ptosis, a wide-based and ataxic gait with short strides, inability to stand without support, loss of toe/finger proprioception, horizontal and vertical nystagmus, and dysmetria on coordination testing. Strength and sensation were preserved. His work-up included computed tomography and magnetic resonance imaging of the brain, cervical, thoracic, and lumbar spine that demonstrated no acute abnormalities. On hospital day 9, the patient was able to ambulate with mild difficulty. WHY SHOULD AN EMERGENY PHYSICIAN BE AWARE OF THIS?: Toxicity from excessive ethyl chloride huffing has been rarely reported. The toxicity was characterized with cerebellar findings, no attributable laboratory abnormalities, and no radiographic abnormalities on computed tomography/magnetic resonance imaging. The neurotoxicity resolved with supportive care. This case of excessive huffing of ethyl chloride presenting with neurotoxicity and ataxia further characterizes a rare complication of ethyl chloride toxicity that is gaining popularity.
Asunto(s)
Ataxia Cerebelosa , Cloruro de Etilo , Síndromes de Neurotoxicidad , Masculino , Humanos , Adulto , Síndromes de Neurotoxicidad/etiología , Ataxia , Anestésicos LocalesRESUMEN
BACKGROUND: Hydroxychloroquine overdose is rare but potentially lethal. Hydroxychloroquine overdose symptoms are characterized by central nervous system toxicity, cardiac toxicity, and hypokalemia. Recommended treatment consists of epinephrine, high-dose diazepam, and careful potassium repletion. Few pediatric hydroxychloroquine overdoses have been reported. CASE REPORT: We describe a 14-year-old girl who ingested 10 g (172 mg/kg) of hydroxychloroquine. She developed tachycardia, hypotension, and hypokalemia. She was intubated and treated with diazepam and epinephrine infusions and potassium supplementation. Her serum hydroxychloroquine concentration obtained 10 h after ingestion was 13,000 ng/mL (reference range 500-2000 ng/mL). The patient made a full medical recovery. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Pediatric hydroxychloroquine overdoses are reported rarely, and the toxic and lethal doses of hydroxychloroquine ingestion have not been established. This case of a teenaged patient who ingested 10 g of hydroxychloroquine and survived provides additional information that may be used to help establish toxic and lethal doses of ingestion.
Asunto(s)
Sobredosis de Droga , Hipopotasemia , Adolescente , Niño , Diazepam/uso terapéutico , Sobredosis de Droga/tratamiento farmacológico , Ingestión de Alimentos , Epinefrina/uso terapéutico , Femenino , Humanos , Hidroxicloroquina/efectos adversos , Potasio/uso terapéuticoRESUMEN
BACKGROUND: Identification of portal venous gas on radiographic imaging is well documented after the ingestion of hydrogen peroxide, as is its resolution after hyperbaric therapy. Although hyperbaric therapy may resolve the gastrointestinal symptoms associated with the presence of portal venous gas, the principle rationale for performing hyperbaric therapy is to prevent subsequent central nervous system oxygen embolization. CASE REPORT: We describe a patient with portal venous gas identified by computed tomography after the ingestion of 3% hydrogen peroxide, managed without hyperbaric therapy, who subsequently developed portal venous thrombosis. We are not aware of this complication being previously described from hydrogen peroxide ingestion. The case is complicated by the coexistence of a self-inflicted stab wound, leading to exploratory laparotomy in a patient predisposed to arterial vascular occlusion. Why Should an EmergencyPhysicianBeAware of This? Emergency physicians will encounter patients after the ingestion of hydrogen peroxide who, despite not having symptoms of central nervous system emboli, have portal venous gas identified on radiographic imaging. Being aware that the principle rationale for prophylactic utilization of hyperbaric therapy is to prevent subsequent central nervous system emboli, and that in at least one case, delayed-onset portal venous thrombosis has occurred without hyperbaric therapy may help contribute to clinical decision-making.
Asunto(s)
Embolia Aérea , Oxigenoterapia Hiperbárica , Trombosis de la Vena , Ingestión de Alimentos , Embolia Aérea/etiología , Embolia Aérea/terapia , Humanos , Peróxido de Hidrógeno/efectos adversos , Vena Porta/diagnóstico por imagen , Trombosis de la Vena/etiologíaRESUMEN
BACKGROUND: Perampanel is a new antiepileptic used to treat partial-onset seizures and generalized tonic-clonic seizures in people older than 12 years old. Perampanel is a selective, non-competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist, with a prolonged half-life of approximately 105 hours. Few cases of significant toxicity have been reported, and effects in overdose are poorly understood. CASE REPORT: This case describes a 20-month-old healthy female who ingested 8 mg of perampanel. She presented to a pediatric emergency department 1 hour after ingestion with ataxia, irritability, and somnolence. Vital signs were: heart rate 130 beats per minute, blood pressure 112/97 mmHg, temperature 99°F, respiratory rate 30 breaths per minute. She was admitted to the pediatric intensive care unit. During the hospitalization, she developed hypotension and bradycardia which improved with stimulation and fluid resuscitation. Intermittent bradycardia persisted for 32 hours after ingestion. Physical examination was notable for somnolence and truncal ataxia with irritability when aroused, all of which improved throughout the hospitalization. A quantitative level obtained on hospital day 3 (HD) was 750ng/ml. On HD 3 the patient was noted to be ataxic but otherwise had an age-appropriate neurologic examination. She was discharged on HD 4 with normal vital signs, return to baseline mental status, and baseline gait. The patient's cardiovascular, neurologic, and behavioral symptoms were attributed to perampanel toxicity. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS ?: Toxicity from a perampanel overdose is poorly understood both in adults and pediatric patients with significant cardiovascular, behavioral, and central nervous system abnormalities.
Asunto(s)
Nitrilos , Piridonas , Adulto , Anticonvulsivantes/efectos adversos , Niño , Femenino , Humanos , Lactante , Nitrilos/uso terapéutico , Piridonas/efectos adversos , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Resultado del TratamientoRESUMEN
BACKGROUND: Neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) are serious medical conditions associated with commonly prescribed psychiatric medications. Although the mechanisms differ, they can be clinically difficult to distinguish. We report a case of a pediatric patient with complicated psychiatric history that developed features of both syndromes in the setting of polypharmacy. CASE: A 12-year-old boy with a history of developmental delay, attention-deficit hyperactivity disorder, and posttraumatic stress disorder presented to the emergency department with behavior changes consisting of delayed reactions, gait instability, drooling, and slowed movements. Ten days before presentation, his outpatient psychiatrist had made multiple medication changes including discontinuation of cyproheptadine (an appetite stimulant) and initiation of aripiprazole. On arrival, the patient was noted to be tachycardia and hypertensive for age. He was disoriented, intermittently agitated, and tremulous with increased tonicity, clonus in the lower extremities, and mydriasis. He was supportively treated with lorazepam and intravenous fluids while discontinuing potential offending agents. His course was complicated by hypertension and agitation managed with dexmedetomidine infusion and benzodiazepines. His mental status, tremors, and laboratory values began to improve over the next 2 days, and eventually transitioned to the inpatient psychiatric unit on hospital day 7. DISCUSSION: Diagnosis of NMS or SS can be difficult when there is overlap between syndromes, particularly in the setting of multiple potential offending agents or underlying developmental delay. In addition, pediatric patients may present atypically as compared with adult patients with the same condition. CONCLUSION: The use of antipsychotic medications for young children with behavioral problems has risen dramatically in the last decade, increasing their risk for developing SS or NMS.
Asunto(s)
Antipsicóticos/efectos adversos , Síndrome Neuroléptico Maligno/diagnóstico , Síndrome de la Serotonina/diagnóstico , Niño , Diagnóstico Diferencial , Humanos , Masculino , PolifarmaciaRESUMEN
OBJECTIVE: Characterize clinical presentations and outcomes of dabigatran and rivaroxaban exposures reported to a poison control system. METHODS: Data for cases of dabigatran and rivaroxaban exposures called into the California Poison Control System from January 2011 to July 2013 were collected. Data collected included patient demographics, type of exposure, medication, dosage, vital signs, laboratory values, interventions, outcomes, and disposition. Exclusion criteria included confirmed nonexposures or miscoded cases. RESULTS: A total of 56 cases were identified, with 7 excluded, leaving 37 dabigatran and 12 rivaroxaban cases. Children age 12 years or less accounted for 5 dabigatran and 2 rivaroxaban cases. Bleeding was reported in 15 dabigatran cases. There were 4 cases of acute self-harm overdose with dabigatran ranging from 1800 to 3900 mg. Mild bleeding was reported in only one of these overdose cases. There were 2 fatal hemorrhages in dabigatran cases, both in chronic therapeutic dosing. Bleeding was reported in 5 rivaroxaban cases, all in patients with chronic exposure; no deaths were reported. There were no adverse outcomes in pediatric patients. Coagulation parameters did not correlate well with bleeding. CONCLUSIONS: In our series, the greatest risk of adverse events was in patients chronically taking these agents, irrespective of excess dosing. Acute self-harm ingestions and accidental pediatric ingestions had few adverse effects, although massive overdose can lead to abnormal coagulation studies. It does not appear that single low-dose ingestions of either medication will lead to clinically significant bleeding. It may be possible to manage some pediatric exposures and most accidental ingestions with observation.
Asunto(s)
Anticoagulantes/envenenamiento , Bencimidazoles/envenenamiento , Morfolinas/envenenamiento , Tiofenos/envenenamiento , beta-Alanina/análogos & derivados , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , California/epidemiología , Niño , Preescolar , Dabigatrán , Sobredosis de Droga/epidemiología , Sobredosis de Droga/terapia , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Centros de Control de Intoxicaciones/estadística & datos numéricos , Estudios Prospectivos , Estudios Retrospectivos , Rivaroxabán , Adulto Joven , beta-Alanina/envenenamientoRESUMEN
OBJECTIVES: This retrospective study aims to review California Poison Control System data to qualitatively describe reported methyl acetate (MA) exposures and determine if a metabolic acidosis develops. METHODS: We queried the Poison Control System data between January 1997 and December 1, 2010. Inclusion criteria were single MA ingestions. RESULTS: Eighty-three cases were analyzed. Females made up 52% of study subjects. Seventy-five cases (90%) were 5 years or younger. Most (93%) ingestions were unintentional. Sixty-two cases (75%) were referred to a health care facility (HCF). Of these, 75% of cases referred to an HCF had no effect, and 25% of cases had a minor effect. There were no major effects, including deaths reported. One case received single-dose activated charcoal, and 1 case received intravenous fluids as therapy. All other cases were observed only. Of all cases, including home-managed and HCF cases, 63 (76%) had no symptoms. Vomiting was observed in 12 cases (14%), drowsiness in 1 case, ataxia in 1 case, abdominal pain in 1 case, and throat/oral irritation in 5 cases. Fifty-three percent of cases referred to HCF had at least 1 chemistry panel done (27% had >1 chemistry panel done). One patient had a mild metabolic acidosis without symptoms that resolved after a period of observation. There was no renal dysfunction. CONCLUSION: These data suggest that minor ingestions of MA may be observed at home, but a prospective study is needed to exclude the risk of home observation.
Asunto(s)
Acetatos/efectos adversos , Metanol/envenenamiento , Adolescente , California/epidemiología , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Centros de Control de Intoxicaciones , Estudios Retrospectivos , Solventes/efectos adversos , Adulto JovenRESUMEN
BACKGROUND: Although the 3 to 4 gram per 24 hours dose recommended for daily use are generally safe, case reports and some series raise concerns about nonacute excessive doses in some individuals. OBJECTIVE: To assess the safety of dosing more than 4 grams of acetaminophen in a 24-hour period in hospitalized patients and develop a method to evaluate the ongoing practice of acetaminophen dosing. Methods: We performed a retrospective chart review of supratherapeutic doses of acetaminophen over a 2-year period. Outcomes included death and the need for liver transplant. A "best practices alert" (BPA) was then developed in our EMR when more than 4 grams of acetaminophen was either prescribed or administered in a 24- hour period. Twelve months of alerts were then retrospectively reviewed and evaluated. RESULTS: 152 cases of dosing more than 4 grams were initially identified. No cases of death related to liver failure or liver transplant were found in any of these patients. 482 cases were identified after a BPA was put in place where the alert was overridden. There were no deaths and no cases that required liver transplantation due to liver failure. The majority of overrides were due to the allowed window of timing for nursing administration of acetaminophen for scheduled doses and overlap with as needed dosing. CONCLUSION: Supratherapeutic dosing of acetaminophen in our patients did not lead to death or liver transplant. A BPA in our EMR has allowed better evaluation of patterns of acetaminophen use at our university health system.
Asunto(s)
Analgésicos no Narcóticos , Sobredosis de Droga , Fallo Hepático , Humanos , Acetaminofén , Estudios Retrospectivos , PacientesRESUMEN
INTRODUCTION: An increasing number of jurisdictions have legalized recreational cannabis for adult use. The subsequent availability and marketing of recreational cannabis has led to a parallel increase in rates and severity of pediatric cannabis intoxications. We explored predictors of severe outcomes in pediatric patients who presented to the emergency department with cannabis intoxication. METHODS: In this prospective cohort study, we collected data on all pediatric patients (<18 years) who presented with cannabis intoxication from August 2017 through June 2020 to participating sites in the Toxicology Investigators Consortium. In cases that involved polysubstance exposure, patients were included if cannabis was a significant contributing agent. The primary outcome was a composite severe outcome endpoint, defined as an intensive care unit admission or in-hospital death. Covariates included relevant sociodemographic and exposure characteristics. RESULTS: One hundred and thirty-eight pediatric patients (54% males, median age 14.0 years, interquartile range 3.7-16.0) presented to a participating emergency department with cannabis intoxication. Fifty-two patients (38%) were admitted to an intensive care unit, including one patient who died. In the multivariable logistic regression analysis, polysubstance ingestion (adjusted odds ratio = 16.3; 95% confidence interval: 4.6-58.3; P < 0.001)) and cannabis edibles ingestion (adjusted odds ratio = 5.5; 95% confidence interval: 1.9-15.9; P = 0.001) were strong independent predictors of severe outcome. In an age-stratified regression analysis, in children older than >10 years, only polysubstance abuse remained an independent predictor for the severe outcome (adjusted odds ratio 37.1; 95% confidence interval: 6.2-221.2; P < 0.001). As all children 10 years and younger ingested edibles, a dedicated multivariable analysis could not be performed (unadjusted odds ratio 3.3; 95% confidence interval: 1.6-6.7). CONCLUSIONS: Severe outcomes occurred for different reasons and were largely associated with the patient's age. Young children, all of whom were exposed to edibles, were at higher risk of severe outcomes. Teenagers with severe outcomes were frequently involved in polysubstance exposure, while psychosocial factors may have played a role.
Asunto(s)
Cannabis , Enfermedades Transmitidas por los Alimentos , Alucinógenos , Intoxicación por Plantas , Masculino , Adulto , Adolescente , Niño , Humanos , Preescolar , Femenino , Estudios Prospectivos , Mortalidad Hospitalaria , Psicotrópicos , Servicio de Urgencia en Hospital , Sistema de RegistrosRESUMEN
BACKGROUND: Second-generation antipsychotic medications, or "atypical antipsychotics," are now first-line therapy in the treatment of schizophrenia and other psychotic disorders, and are additionally being used in a wide array of other psychiatric and non-psychiatric conditions in both adults and children. Overdose is frequently reported to poison control centers. OBJECTIVES: We review the toxicology and general management of poisonings involving the atypical antipsychotic medications. DISCUSSION: The most serious toxicity involves the cardiovascular system and the central nervous system. All typical and atypical antipsychotics cause sedation, which is pronounced in overdose. The most common cardiovascular effects that occur after atypical antipsychotic overdose are tachycardia, mild hypotension, and prolongation of the QTc interval. Other clinical syndromes in overdose include neuroleptic malignant syndrome (NMS) and antimuscarinic delirium. Seizures may be observed. No antidotes exist for these poisonings, but they most often do well with supportive care. CONCLUSION: Antipsychotic overdose produces a gamut of manifestations that affect multiple organ systems. Treatment is primarily supportive. Specific therapies for NMS, hypotension, and seizures are discussed.
Asunto(s)
Antipsicóticos/envenenamiento , Sobredosis de Droga , Antipsicóticos/efectos adversos , Arritmias Cardíacas/inducido químicamente , Delirio/inducido químicamente , Manejo de la Enfermedad , Sobredosis de Droga/diagnóstico , Sobredosis de Droga/terapia , Humanos , Síndrome Metabólico/inducido químicamente , Síndrome Neuroléptico Maligno/etiología , Síndrome Neuroléptico Maligno/terapiaRESUMEN
The Green Bush Viper, Atheris squamigera, is native to West and Central Africa and has few well reported envenomations. Bite victims experience dizziness, nausea, headache, regional lymphadenopathy, and localized edema. Most reports also detail severe effects including thrombocytopenia, coagulopathy, hemolysis, hemorrhage, or renal failure. Fatalities are reported, but poorly described. There is no specific antivenom for A. squamigera, but non-species specific antivenom has been reported helpful in several cases. We report the case of a 36-year-old woman who was bitten by a green bush viper and was treated with several non-species specific antivenoms. There were no complications to antivenom administration and the patient experienced a milder envenomation than detailed in previous reports.
RESUMEN
OBJECTIVE: The purpose of this study was to prospectively evaluate electrocardiograms (ECGs) before and after running a half marathon to characterize the changes that occur after exertion. Echocardiograms were also done postrace on selected runners. METHODS: Volunteer runners older than 18 years completed a questionnaire detailing demographic and medical history. Prerace ECGs were performed at a prerace symposium and postrace ECGs were performed within 15 minutes of the participants' completion of the race. Echocardiograms were performed on a random sampling of runners who were judged to have abnormal or changed postrace ECGs. RESULTS: Eighty-seven runners were enrolled and completed the study. There were 46 males (53%) and 41 females (47%). Fifty-four (62%) runners had changes noted in their ECGs. The most common changes noted were atrial enlargement (37 runners). Other abnormalities seen on the ECGs included new conduction abnormalities, new Q waves, nonspecific ST/T-wave changes, and resolution of previous abnormalities that were seen on initial ECG. There was no statistically significant difference between runners with ECG changes and runners without ECG changes when comparing sex, age, previous marathon experience, exercise, history of exercise-induced chest pain, medical history, and family history of heart disease. Twenty runners with changed or abnormal postrace ECGs had postrace echocardiograms, and 8 were abnormal. Of the abnormal echocardiograms, 2 runners had normal but changed postrace ECGs and 4 runners had abnormalities that were inconsistent with what was seen on ECG. CONCLUSION: Our study suggests that ECG abnormalities and changes can occur in distance runners, but their significance is unclear.
Asunto(s)
Ecocardiografía , Electrocardiografía , Carrera/fisiología , Adolescente , Adulto , Anciano , Femenino , Corazón/fisiología , Humanos , Masculino , Persona de Mediana Edad , Miocardio/patología , Estudios Prospectivos , Adulto JovenRESUMEN
BACKGROUND: Salicylate poisoning is a common problem with appreciable morbidity and mortality. We present a case of a patient with a large aspirin ingestion who expired despite aggressive hemodialysis (HD). CASE REPORT: A 35-year-old man arrived at the Emergency Department 7.5 h after ingesting 400 tablets of 325-mg aspirin. He was afebrile, the respiratory rate (RR) was 30 breaths/min, heart rate (HR) 120 beats/min, blood pressure (BP) 125/76 mm Hg, and oxygen saturation 99% on room air. His salicylate concentration was 89.6 mg/dL. His initial arterial blood gas: pH 7.48, pCO(2) 21 mm Hg, PaO(2) 97 mm Hg, and bicarbonate 15.8 mmol/L. His initial serum chemistry panel was normal. He received activated charcoal and intravenous hydration with sodium bicarbonate. Two hours after arrival, salicylate concentration was 91.6 mg/dL. The patient became agitated and HD was initiated; 22 h after presentation, repeat salicylate concentration was 88.4 mg/dL and his creatinine was 3.9 mg/dL. A second run of HD was performed. After this, his temperature had risen to 39.06°C (102.3°F), BP 122/64 mm Hg, HR 168 beats/min, RR 43 breaths/min, and oxygen saturation 95% (2 L nasal cannula). His confusion increased, and he died 40 h after his ingestion. CONCLUSION: HD is widely advocated in managing severe salicylate intoxications, however, no consensus exists for the duration and best mode of therapy. Patients with severe salicylate poisonings may require extended durations of HD to effectively mitigate toxicity. Additional study is warranted to determine optimal therapy in severe salicylate intoxications.
Asunto(s)
Intoxicación/terapia , Diálisis Renal , Ácido Salicílico/envenenamiento , Adulto , Carbón Orgánico/administración & dosificación , Resultado Fatal , Humanos , Masculino , Bicarbonato de Sodio/administración & dosificación , SuicidioRESUMEN
INTRODUCTION: Aseptic inflammatory arthritis has been reported from thorns or cactus needles after inadvertent arthrotomy. Agave sap irritants may cause an aseptic inflammatory arthritis mimicking a septic joint. CASE REPORT: A 27-year-old male presented with left knee pain and swelling two hours after suffering an accidental stab wound to his left lateral knee by an agave plant spine. Synovial fluid white blood cell count was 92,730 mm3 with 75% neutrophils and no crystals. Surgical washout was remarkable for turbid fluid and no foreign body. Synovial fluid and blood cultures remained without growth. At two-week follow-up, the patient had recovered. CONCLUSION: Penetrating injuries from agave thorns can cause an inflammatory arthritis that mimics septic arthritis.
RESUMEN
BACKGROUND: Despite concern that the global pandemic will worsen depression and suicide rates, there remain little data on its actual effect. The purpose of this study was to determine the effect of the COVID-19 pandemic on suicidal ingestions reported to the California Poison Control System (CPCS). METHODS: This was a cross-sectional comparison of suicidal ingestions reported to the CPCS during the 2020 COVID-19 pandemic compared to suicidal ingestions reported during the same period in 2018 and 2019. RESULTS: The CPCS received 19,607 call for suicidal ingestions during the study periods, of which 13,800 were in the pre-COVID era (2018 and 2019) and 5,807 were in the COVID era. The median (IQR) number of suicidal ingestions per month decreased from 2,286 (2,240-2,364) to 1,940 (1,855-2,045; p = 0.02). This decrease was consistent and significant across all age groups except those age 70 or older. Ingestions without adverse events decreased by 101 cases/month (95% confidence interval [CI] = 136.8 to 65; p = 0.0003), minor outcomes decreased by 156.6 cases/month (95% CI = 226.2 to 87.1; p = 0.001), and moderate outcomes decreased by 96 cases/month (95% CI = 143.9 to 48.1; p = 0.00021). Major outcomes decreased from 793 (4.99%) cases in the pre-COVID era to 315 (4.60%) cases in the COVID era (risk ratio = 0.92, 95% CI = 0.81 to 1.05). The number of deaths decreased by 3.7 cases/month (95% CI = -8.3 to 0.92, p = 0.10). CONCLUSIONS: Despite concern for worsening suicidality, calls regarding suicidal ingestions to the nation's largest poison control center decreased during the COVID era compared to the pre-COVID era. This study provides evidence that the pandemic's effects on modern society remain difficult to predict. Further effort is needed to understand how pandemic will affect American's mental health.
Asunto(s)
COVID-19 , Venenos , Anciano , California/epidemiología , Estudios Transversales , Ingestión de Alimentos , Humanos , Pandemias , SARS-CoV-2 , Ideación SuicidaRESUMEN
BACKGROUND: Marathon running has surged in popularity in the last quarter century. A small percentage of marathon runners develop increases of myocardial-specific markers with exercise, sometimes in the diagnostic range for acute myocardial infarction. A spectrum of abnormal electrocardiogram (ECG) patterns has also been described. OBJECTIVE: ECG change specifically after marathon running has not been reported and may further the understanding of the interrelation of intense physical exertion and cardiac structure and function. CASE REPORT: Two patients who presented to the Emergency Department on June 3, 2007 after participating in an inner-city full marathon (26.2 miles) with very similar abnormal ECGs that met criteria for acute myocardial infarction were included in this case report. Cardiac biomarker analysis and ECGs were recorded. Both runners were admitted to the hospital and underwent coronary catheterization. One runner (Runner 1) had no coronary artery disease on catheterization and his troponin I peaked at 0.3 ng/mL. The other runner (Runner 2) had 99% occlusion of his left anterior descending artery and his troponin I peaked at 13.4 ng/mL. CONCLUSION: Previously asymptomatic individuals under extreme physical exertion may be at risk for myocardial stress and myocyte injury. Abnormal ECG patterns in patients under these conditions may not correlate with structural cardiovascular disease.
Asunto(s)
Conducta Competitiva , Forma MB de la Creatina-Quinasa/metabolismo , Creatinina/metabolismo , Electrocardiografía , Péptido Natriurético Encefálico/sangre , Carrera/estadística & datos numéricos , Troponina I/sangre , Adulto , Humanos , Masculino , Persona de Mediana Edad , Deportes/estadística & datos numéricosRESUMEN
BACKGROUND: Isoniazid (INH) is an effective treatment for tuberculosis and among the most common causes of drug-induced seizures in the United States. Isoniazid intoxication produces a characteristic clinical syndrome including seizures, metabolic acidosis, and, in severe cases, respiratory depression and coma. CASE: A 10-month-old male infant was presented after being found with his father's INH. The patient was brought to a local hospital where he had a witnessed generalized seizure and was given 650 mg pyridoxine intravenously, which was based on a 70 mg/kg recommendation. Five hours after the time of ingestion, the patient developed recurrent generalized seizures. He was given diazepam and then loaded with phenobarbital 20 mg/kg, while awaiting more pyridoxine from the pharmacy. He received an additional 2 g pyridoxine for a suspected ingestion of approximately 2.7 g INH (290 mg/kg total dose), and his seizures subsequently resolved. DISCUSSION: Treatment of INH toxicity must address correction of gamma-aminobutyric acid deficiency with pyridoxine replacement and management of life-threatening events. For poisonings in which the amount of INH ingested is known, pyridoxine is dosed on a gram-for-gram basis. Several reference textbooks recommend pyridoxine dosing in children to be 70 mg/kg. This was the justification for the initial pyridoxine dose administered in our case. However, after review of the referenced literature, the rationale supporting this recommendation remains unclear. Benzodiazepines should also be given with pyridoxine as they have been shown to have a synergistic effect in terminating seizures in animal models. CONCLUSIONS: As soon as possible after INH overdose is suspected or diagnosed, pyridoxine should be administered in a dose approximately equal to the estimated amount of INH ingested regardless of the age of the patient.
Asunto(s)
Antituberculosos/envenenamiento , Isoniazida/envenenamiento , Piridoxina/administración & dosificación , Estado Epiléptico/inducido químicamente , Complejo Vitamínico B/administración & dosificación , Diagnóstico Diferencial , Relación Dosis-Respuesta a Droga , Sobredosis de Droga , Humanos , Lactante , Infusiones Intravenosas , Masculino , Piridoxina/efectos adversos , Estado Epiléptico/diagnóstico , Estado Epiléptico/tratamiento farmacológico , Complejo Vitamínico B/efectos adversosRESUMEN
BACKGROUND: Most Americans take at least one medication on a daily basis. Inadvertently ingesting a double-dose of a medication with a narrow therapeutic index may lead to adverse effects. When a patient or medical professional contacts the local poison center after an overdose, a poison specialist fields the incoming information and, depending on the caller, provides specific recommendations. We sought to determine which medication classes were most likely to lead to significant adverse outcomes when an extra dose was ingested. METHODS: This was a retrospective review of all double-dose medication ingestions reported to the California Poison Control System (CPCS) between January 2006 and December 2015. Inclusion criteria were single-instance, single-medication ingestions where the dose was known. All ages and both sexes were included. We evaluated generalized outcomes per AAPCC criteria stratified as no effect, minor, moderate, major or death. We also documented specific symptoms and interventions noted by the poison control specialists. RESULTS: Out of 1286 cases, 876 ingestions met the inclusion criteria. Medications with antihypertensive and behavior modulating effects each accounted for over a third of all moderate and major effects. The medications/medication classes implicated in the 12 major outcomes included propafenone, beta blockers (ßBs), calcium channel blockers (CCBs), bupropion, and tramadol. Of these, vasoactive medications were associated with the most severe effects requiring cardiac pacing and vasopressor drips. Analgesics, antimicrobials, and anti-allergy medications were well tolerated. There were no deaths. CONCLUSIONS: Major adverse outcomes after a double dose ingestion were rare. Most double dose medication ingestions can be safely monitored at home, albeit with a few exceptions. Vigilance is warranted in cases of ßB and CCB ingestion due to the risk of hemodynamic collapse or seizures with tramadol and bupropion.